The first oral modified live vaccine for protection against Lawsonia intracellularis.

• Provides active live protection of gut health by stimulating the mucosal immune response, significantly reducing gross and microscopic intestinal lesions of Ileitis.

• Single dose, oral delivery through the water supply which directly enters the intestinal tract, and provides a convenient, easy-to-administer method that saves labour costs and time.

• Quality assurance friendly – no needles.

When you evaluate the importance of a pig’s intestinal health, the science behind using a modified-live vaccine to actively stimulate a mucosal immune response, the ease and direct approach of a vaccine administered through the water supply, and the proven efficacy of protecting more than a billion pigs globally over two decades, Enterisol^® Ileitis is the good gut decision backed by evidence and performance.

The only swine vaccine offering proven cross-protection against the emerging monophasic Salmonella strain¹.

• The only dual-antigen swine Salmonella vaccine, containing both Salmonella Choleraesuis and Salmonella Typhimurium antigens in one dose.

• Single dose, oral delivery through the water supply which directly enters the intestinal tract, and provides a convenient, easy-to-administer method that saves labour costs and time.

• Modified-live vaccine provides rapid onset of immunity after administration and induction of crucial cellular immunity toward Salmonella.

• Quality assurance friendly – no needles.

Salmonella can present significant challenges to herd health and productivity. Salmonella Typhimurium also poses food safety risks to humans. As the first and only vaccine offering live attenuated strains of both Choleraesuis and Typhimurium, Enterisol Salmonella T/C^® allows you to reduce risks of both serovars, as well as the emerging monophasic strain, in a single, oral dose.

1. Leite, FLL et al. Vaccination against Lawsonia intracellularis decreases shedding of Salmonella enterica serovar Typhimurium in co-infected pigs and alters the gut microbiome. Scientific Reports (2018) 8:2857.

Providing safe, effective control of porcine circovirus-associated disease (PCV2) in a single dose.

• Purified with DiaTEC, a patented diafiltration process resulting in the highly immunogenic and non-virucidal Ingelvac CircoFLEX^®.

• Contains ImpranFLEX^®, providing a strong immune response with low risk of injection site lesions or other adverse reactions in pigs.

• First approved vaccine to protect sows from PCV2 associated disease for whole herd protection.

• Single dose, 1 mL vaccine, reducing pig handling and stress.

• Provides effective immune response two weeks after vaccination and at least four months of immunity, lasting through the grow-finish stage.

• Approved for pigs three weeks of age or older.

Ingelvac CircoFLEX^® is the first in the FLEX family of swine vaccines and one of the most revolutionary PCV2 vaccines on the market. It has built a reputation for providing safe, effective control of PCVAD in pigs three weeks of age or older from a single dose. Unlike two-dose products, it provides effective immune response within two weeks after single-dose vaccination.

Proven to reduce lung lesions and pneumonia associated with Mycoplasma hyopneumoniae (Mhp) infection².

• Single dose, 1 mL vaccine that can be administered to pigs three weeks of age or older to best fit your program.

• Provides at least 26 weeks of immunity, lasting through to market.

• Rapid onset of immunity and low risk of adverse reactions in pigs from ImpranFLEX^® adjuvant technology.

Mhp is a leading cause of respiratory disease throughout the entire swine industry. Controlling Mhp infection within the entire production chain provides optimum results. Ingelvac MycoFLEX^® has been proven to reduce lung lesions and pneumonia associated with Mhp infection. A recent study showed piglets had a reduction in colonization compared to non-vaccinates².

2. Fano E, Cline G. Mycoplasma hyopneumoniae microbial load and histological lesion reduction in piglets vaccinated with MycoFLEX. Proceedings. IPVS-ESPHM 2016, Dublin, Ireland, 237.

The leading modified live porcine reproductive and respiratory syndrome (PRRS) vaccine in Canada³.

• Proven efficacy and safety for all stages of production – pigs, gilts and sows.

• Demonstrated significant cross protection against most current relevant heterologous wild-type PRRS virus strains.

• The only vaccine that has demonstrated proven efficacy and safety in all stages and phases of production for building or maintaining whole herd immunity.

• Demonstrated mitigation of the consequences of infection, reducing clinical disease, while also reducing the magnitude and duration of viremia and shedding of wild-type PRRSv within and from vaccinated populations.

• The only PRRS vaccine approved by the Canadian Centre for Veterinary Biologics for use in the widest range of combinations – 3FLEX^®, FLEX Combo and FLEX CircoPRRS^® – to best meet the needs of your protocol.

Ingelvac^® PRRS MLV, a leading modified-live PRRS vaccine, has been trusted for over 25 years to protect the swine industry against reproductive and respiratory symptoms of PRRSv.

3. Impact Vet, 2022.

The only all-in-one vaccine approved for use in swine to control Porcine Circovirus Type 2 (PCV2), Mycoplasma hyopneumoniae (Mhp) and Porcine Reproductive and Respiratory Syndrome (PRRS).

• Provides you with the ability to customize your disease control program where all three diseases are present.

• 3FLEX^® is easy to mix and is administered in a single 2-mL injection to pigs three weeks of age or older, reducing labour and stress of injecting pigs multiple times.

• Extensive research shows lack of interference between antigens and high level of immunization and product efficacy.

• Rapid onset of immunity and low risk of adverse reactions in pigs from ImpranFLEX^® adjuvant technology.

• Contains DiaTEC, resulting in a non-virucidal vaccine, providing producers and veterinarians with greater versatility.

As part of the FLEX Family of swine vaccines, 3FLEX^® provides you the ultimate in customization for control of three respiratory diseases in swine: PCV2, Mhp and PRRS. For most swine producers, a single 2-mL dose of 3FLEX^® replaces multiple injections of monovalent vaccines, saving time, labour, and the hassle and stress of handling pigs multiple times. The 3FLEX^® package contains one bottle of Ingelvac CircoFLEX^®, one bottle of Ingelvac MycoFLEX^® and one bottle of Ingelvac^® PRRS MLV.

The industry’s first avirulent live, single dose Glässer’s disease vaccine.

• Avirulent live, single dose vaccine against Glaesserella parasuis (GP), formerly known as Haemophillus parasuis (HP), that aids in the protection from Glässer’s disease.

• ParaSail^® is shown to provide protection against one of the most common strains of GP in circulation (serovar 5).

• Saves producers time and money with single dose administration.

• Reduces stress on pigs and causes minimal tissue disruption with low dosage of 1 mL.

GP is a frequently identified pathogen on respiratory tissues and is frequently associated with porcine reproductive and respiratory syndrome (PRRS), influenza A virus in swine (IAV-S), Mycoplasma hyorhinis (M. hyorhinis) and Streptococcus suis (S. suis). The duration of GP can be short, but it causes a high mortality rate if left untreated. In less than 48 hours, this pathogen can cause systemic infection and death. Other effects include systemic lesions characterized by arthritis, polyserositis and meningitis. ParaSail^® is an intramuscularly administered avirulent live, single-dose Glaesserella parasuis vaccine that aids in the protection from Glässer’s disease.

A safe, effective one-dose live Erysipelothrix rhusiopathiae (erysipelas) vaccine.

• Single dose, oral vaccination delivered through the water source, reducing animal stress and saving you time and money.

• Provides 128 days of immunity.

• Recommended for the vaccination of healthy, susceptible pigs eight weeks of age or older.

• Quality assurance friendly – no needles

Ingelvac^® ERY-ALC is a safe, effective, one-dose live Erysipelothrix  rhusiopathiae  (erysipelas) vaccine. It is administered orally and is recommended for the vaccination of healthy, susceptible swine eight weeks of age or older as an aid in the prevention of disease caused by Erysipelothrix  rhusiophathiae  (erysipelas).